CFCThe Compounder Score
RMD logo

RMD — ResMed Inc.

Medical Instruments & SuppliesHealthcare

$239.53

+$0.64 (+0.27%)

ResMed Inc. engages in the digital health and cloud-connected medical devices business in the United States and internationally. It operates in two segments, Sleep and Breathing Health, and Residential Care Software.

Market Cap

$33.69B

Forward P/E

18.1x

52-Week Range

N/A

RMD Price History

No cached price history available for this ticker yet.

Revenue vs. Net Income

$5.7B

Revenue · FY2026

Annual. Net margin is shown under each year.

RevenueNet income (green profit, red loss)

Free Cash Flow

$1.6B

FCF · FY2026

Annual. FCF margin is shown under each year.

Return on Capital Employed (ROCE)

25.2%

ROCE · FY2026

Annual. Green above 0%, red below. Dashed line marks the 15% compounder threshold.

Total Assets vs. Total Liabilities

3.8x

Assets ÷ liabilities · FY2026

Annual. What the company owns against what it owes. Assets ÷ liabilities is shown under each year.

Total assetsTotal liabilities

CapEx as % of Revenue

3.1%

CapEx · FY2026

Annual. Green at or under the 5% maximum target, red above it.

Shares Outstanding

146.1M

Diluted shares · FY2026

Annual diluted shares. Under each year: the change on the previous year (green = buyback, amber = dilution).